Cargando…

Epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the Zoroastrian population in Yazd, Iran: a WHO-ILAR COPCORD study (stage 1)

BACKGROUND: The purpose of this study was to determine the prevalence of musculoskeletal complaints, rheumatologic diseases, and disability among the Zoroastrian population in Iran. METHODS: The city of Yazd, in central Iran was selected for this study, with the highest population of Zoroastrians in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghan, Ali, Soleimani Salehabadi, Hossein, Jamshidi, Ahmadreza, Kamali, Zohre, Mali, Mojgan, Faezi, Seyedeh Tahereh, Baghdadi, Azarakhsh, Alesaeidi, Sogol, Sahraei, Fatemeh, Azizi, Niloufar, Zand, Sanaz, Yasini, Sara Sadat, Namazi, Maryam, Daya, Atefe, Nazemian, Ryan, Shamsi, Farimah, Nejadhosseinian, Mohammad, Davatchi, Fereydoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561944/
https://www.ncbi.nlm.nih.gov/pubmed/34724982
http://dx.doi.org/10.1186/s41927-021-00214-2
_version_ 1784593170178244608
author Dehghan, Ali
Soleimani Salehabadi, Hossein
Jamshidi, Ahmadreza
Kamali, Zohre
Mali, Mojgan
Faezi, Seyedeh Tahereh
Baghdadi, Azarakhsh
Alesaeidi, Sogol
Sahraei, Fatemeh
Azizi, Niloufar
Zand, Sanaz
Yasini, Sara Sadat
Namazi, Maryam
Daya, Atefe
Nazemian, Ryan
Shamsi, Farimah
Nejadhosseinian, Mohammad
Davatchi, Fereydoun
author_facet Dehghan, Ali
Soleimani Salehabadi, Hossein
Jamshidi, Ahmadreza
Kamali, Zohre
Mali, Mojgan
Faezi, Seyedeh Tahereh
Baghdadi, Azarakhsh
Alesaeidi, Sogol
Sahraei, Fatemeh
Azizi, Niloufar
Zand, Sanaz
Yasini, Sara Sadat
Namazi, Maryam
Daya, Atefe
Nazemian, Ryan
Shamsi, Farimah
Nejadhosseinian, Mohammad
Davatchi, Fereydoun
author_sort Dehghan, Ali
collection PubMed
description BACKGROUND: The purpose of this study was to determine the prevalence of musculoskeletal complaints, rheumatologic diseases, and disability among the Zoroastrian population in Iran. METHODS: The city of Yazd, in central Iran was selected for this study, with the highest population of Zoroastrians in Iran. Subjects were selected by cluster sampling of 9 neighborhoods populated with Zoroastrians. Subjects ≥15 years old were interviewed by trained interviewers in their houses. The validated Farsi translation of Community Oriented Program for the Control of Rheumatic Disease (COPCORD) Core Questionnaire (CCQ) was used for this study. Subjects with musculoskeletal complaints (pain, stiffness and/or swelling) were examined by a rheumatologist. Laboratory tests and radiographic exams were performed when deemed necessary. RESULTS: Two-thousand subjects were interviewed during a 12-month period, of which 956 were male, and 1044 were female. The mean age was 41.1 ± 18.3 years (95%CI: 40.3–41.9). 36.9% of the subjects had university-level education. In the 7 days prior to the interview, 27.6% of the subjects had musculoskeletal complaints, with the knee, dorsolumbar spine, and shoulder being the most common sites of complaints. The most common rheumatologic diagnoses were osteoarthritis (21.5%) and low back pain (10.3%). Rheumatoid arthritis was diagnosed in 1.2% of the subjects. CONCLUSIONS: The epidemiology of musculoskeletal complaints and rheumatologic disorders was inconsistent with previous COPCORD studies in Iran, with a lower prevalence of musculoskeletal complaints in general, lower rates of Behçet and lupus, and a higher prevalence of rheumatoid arthritis. The findings of this study can be for development of better prevention, screening, and treatment programs for the vulnerable population of Zoroastrians in Iran.
format Online
Article
Text
id pubmed-8561944
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85619442021-11-03 Epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the Zoroastrian population in Yazd, Iran: a WHO-ILAR COPCORD study (stage 1) Dehghan, Ali Soleimani Salehabadi, Hossein Jamshidi, Ahmadreza Kamali, Zohre Mali, Mojgan Faezi, Seyedeh Tahereh Baghdadi, Azarakhsh Alesaeidi, Sogol Sahraei, Fatemeh Azizi, Niloufar Zand, Sanaz Yasini, Sara Sadat Namazi, Maryam Daya, Atefe Nazemian, Ryan Shamsi, Farimah Nejadhosseinian, Mohammad Davatchi, Fereydoun BMC Rheumatol Research Article BACKGROUND: The purpose of this study was to determine the prevalence of musculoskeletal complaints, rheumatologic diseases, and disability among the Zoroastrian population in Iran. METHODS: The city of Yazd, in central Iran was selected for this study, with the highest population of Zoroastrians in Iran. Subjects were selected by cluster sampling of 9 neighborhoods populated with Zoroastrians. Subjects ≥15 years old were interviewed by trained interviewers in their houses. The validated Farsi translation of Community Oriented Program for the Control of Rheumatic Disease (COPCORD) Core Questionnaire (CCQ) was used for this study. Subjects with musculoskeletal complaints (pain, stiffness and/or swelling) were examined by a rheumatologist. Laboratory tests and radiographic exams were performed when deemed necessary. RESULTS: Two-thousand subjects were interviewed during a 12-month period, of which 956 were male, and 1044 were female. The mean age was 41.1 ± 18.3 years (95%CI: 40.3–41.9). 36.9% of the subjects had university-level education. In the 7 days prior to the interview, 27.6% of the subjects had musculoskeletal complaints, with the knee, dorsolumbar spine, and shoulder being the most common sites of complaints. The most common rheumatologic diagnoses were osteoarthritis (21.5%) and low back pain (10.3%). Rheumatoid arthritis was diagnosed in 1.2% of the subjects. CONCLUSIONS: The epidemiology of musculoskeletal complaints and rheumatologic disorders was inconsistent with previous COPCORD studies in Iran, with a lower prevalence of musculoskeletal complaints in general, lower rates of Behçet and lupus, and a higher prevalence of rheumatoid arthritis. The findings of this study can be for development of better prevention, screening, and treatment programs for the vulnerable population of Zoroastrians in Iran. BioMed Central 2021-11-02 /pmc/articles/PMC8561944/ /pubmed/34724982 http://dx.doi.org/10.1186/s41927-021-00214-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Dehghan, Ali
Soleimani Salehabadi, Hossein
Jamshidi, Ahmadreza
Kamali, Zohre
Mali, Mojgan
Faezi, Seyedeh Tahereh
Baghdadi, Azarakhsh
Alesaeidi, Sogol
Sahraei, Fatemeh
Azizi, Niloufar
Zand, Sanaz
Yasini, Sara Sadat
Namazi, Maryam
Daya, Atefe
Nazemian, Ryan
Shamsi, Farimah
Nejadhosseinian, Mohammad
Davatchi, Fereydoun
Epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the Zoroastrian population in Yazd, Iran: a WHO-ILAR COPCORD study (stage 1)
title Epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the Zoroastrian population in Yazd, Iran: a WHO-ILAR COPCORD study (stage 1)
title_full Epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the Zoroastrian population in Yazd, Iran: a WHO-ILAR COPCORD study (stage 1)
title_fullStr Epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the Zoroastrian population in Yazd, Iran: a WHO-ILAR COPCORD study (stage 1)
title_full_unstemmed Epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the Zoroastrian population in Yazd, Iran: a WHO-ILAR COPCORD study (stage 1)
title_short Epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the Zoroastrian population in Yazd, Iran: a WHO-ILAR COPCORD study (stage 1)
title_sort epidemiology of musculoskeletal symptoms, rheumatologic disorders, and disability in the zoroastrian population in yazd, iran: a who-ilar copcord study (stage 1)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561944/
https://www.ncbi.nlm.nih.gov/pubmed/34724982
http://dx.doi.org/10.1186/s41927-021-00214-2
work_keys_str_mv AT dehghanali epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT soleimanisalehabadihossein epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT jamshidiahmadreza epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT kamalizohre epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT malimojgan epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT faeziseyedehtahereh epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT baghdadiazarakhsh epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT alesaeidisogol epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT sahraeifatemeh epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT aziziniloufar epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT zandsanaz epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT yasinisarasadat epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT namazimaryam epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT dayaatefe epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT nazemianryan epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT shamsifarimah epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT nejadhosseinianmohammad epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1
AT davatchifereydoun epidemiologyofmusculoskeletalsymptomsrheumatologicdisordersanddisabilityinthezoroastrianpopulationinyazdiranawhoilarcopcordstudystage1